Skip to main content

Post-Market Surveillance

Post-market surveillance (PMS) is the systematic process of collecting, recording, and analysing data on the safety and performance of a medical device throughout its commercial life. Under Decree 98/2021, manufacturers must maintain an active PMS system for devices on the Vietnamese market.

PMS plan

A written PMS plan must be in place before a device enters the Vietnamese market. For registered devices (Type C/D), the PMS plan is part of the registration dossier. The plan should define:

  • Objectives — what safety and performance data is being monitored
  • Data sources — complaint database, literature surveillance, registry data, adverse event reports, field service data
  • Methods — how data will be collected, analysed, and assessed against predefined thresholds
  • Responsible parties — who within the manufacturer's organisation owns each activity
  • Frequency — how often PMS data is reviewed
  • Escalation criteria — what signals will trigger a deeper investigation or FSCA

Data sources for PMS

Data sourceWhat it captures
Complaint handling systemUser and healthcare facility complaints
Adverse event reportsIncidents reported to DAV and received from healthcare facilities
Literature surveillancePublished clinical and technical literature on the device type
Registry and outcomes dataReal-world performance data from registries (where available)
Field service recordsData from repair and maintenance activities
Regulatory database reviewsPublished FSCAs and recalls from other markets

Complaint handling

The manufacturer must maintain a formal complaint-handling procedure covering:

  • Receiving and recording all complaints
  • Initial triage and assessment (is this a reportable incident?)
  • Investigation and root cause analysis
  • Response to the complainant
  • Trending and aggregate analysis

Vietnamese distributors and the Authorised Representative must forward all complaints to the manufacturer promptly.

Periodic summary reports

For Type C and D devices, DAV may request a periodic safety update or PMS summary report. The report should cover:

  • Complaint summary and trend analysis
  • Adverse event reports submitted in the period
  • Any FSCAs or field corrections conducted
  • Literature updates of significance
  • Overall benefit-risk conclusion

When PMS triggers further action

If PMS analysis reveals a safety signal — an unexpected increase in adverse events, a pattern of complaints pointing to a systemic issue, or a literature report of a previously unrecognised risk — the manufacturer must:

  1. Conduct a formal risk assessment
  2. Update the risk management file
  3. If the risk is unacceptable → initiate an FSCA
  4. Report to DAV as appropriate